Prescient Therapeutics Ltd Appoints Thomas Prebet to its Scientific Advisory Board
expand the clinical and translational research program in myeloid malignancies. Dr. Prebet was previously with the Institut Paoli-Calmettes in Marseille France where he was an Associate Professor of Clinical Hematology and a member of the molecular pharmacology group, as well as the early phase trial group and coordinator of the leukemia ward.